EFFICACY OF ONDANSETRON AND METOCLOPRAMIDE AGAINST POSTOPERATIVE NAUSEA AND VOMITING IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY
Article Sidebar
Main Article Content
Abstract
Objectives: Comparing the clinical efficacy of the antiemetics (Ondansetron and Metoclopramide) in preventing postoperative
nausea and vomiting (PONV) in patients undergoing Laparoscopic Cholecystectomy (LC).
Material and Methods: This is a randomised study conducted at anesthesiology department, Khyber Teaching Hospital,
Peshawar, Pakistan from April 2015 to December 2015. Two treatment arms Group A (Ondansetron) and B (Metoclopramide)
were created. A sample of 60 patients was selected in each treatment group.
Results: The overall mean age was 43.42 ± 10.8 years with 37 (30.8%) males and 83 (69.2%) females in a ratio of 1 to
2.24. Overall mean weight was 77.08 ± 9.05 Kg. Mean age in group A was 43.5 ± 10.8 years while it was 43.2 ± 10.9
years. Similarly, mean weight in group A was 76.5 ± 9.3 Kg while it was 77.6 ± 8.8 Kg. A Chi-squared test performed
for treatment group versus the incidence of PONV showed that PONV in group A was 13.3% while in group B it was
27.5% of the total episodes of PONV with a significant association of PONV with group B (p = 0.002). The early PONV
episodes occurred in significantly higher proportion in group B as compared to group A (15% group B versus 6.7%
in group A, p = 0.027). However, late PONV episodes were not significant for any treatment group (6.7% in group A
versus 13.3% in group B, p = 0.068).
Conclusion: Peri-induction use of intravenous ondansetron is an effective alternative than intravenous metoclopramide
in prevention of nausea/vomiting after LC.
Article Details
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.